Aissel Technologies

Aissel Technologies, founded by Prasad Patil, Suraj Prabhu, and Mahesh Grampurohit, is a Pune-based enterprise software company focused on AI-driven solutions for the life sciences sector.

Reviewed by 7wData
Share Email

On this page

Profile

They sell AI software that helps pharmaceutical companies identify and manage relationships with doctors and medical experts.

Aissel Technologies, founded by Prasad Patil, Suraj Prabhu, and Mahesh Grampurohit, is a Pune-based enterprise software company focused on AI-driven solutions for the life sciences sector. The company's flagship product, konectar, is an AI-powered HCP (Healthcare Professional) management platform that analyzes over 2 million HCP profiles by crawling billions of data points, including 80M+ HCP payments, 35M+ medical journal articles, and 479K+ clinical studies. Aissel targets pharmaceutical and medical affairs teams with tools for KOL (Key Opinion Leader) identification, engagement tracking, and compliance management.

The leadership team brings decades of experience from companies like HP, Cybage Software, and Aditya Birla Group. While revenue figures are undisclosed, the company's blog and product updates suggest active engagement with mid-to-large pharma clients, particularly in oncology, CNS, and cardiology specialties. Recent content emphasizes AI-driven predictive analytics for HCP engagement and CRM integration, positioning Aissel in the competitive life sciences SaaS space alongside vendors like Veeva and ZoomInfo.

Track Aissel Technologies and 240+ vendors.

335k+ subscribers read the daily AI & data note. One email, both newsletters. Unsubscribe anytime.

Who buys this

  • Pharmaceutical medical affairs teams
  • Life sciences commercial teams
  • Clinical trial recruitment teams
  • Healthcare compliance officers
  • Medical device manufacturers

Strengths and what to watch

Strengths

  • Proprietary dataset covering 2M+ HCP profiles with 80M+ payment records and 35M+ medical articles
  • CTO Suraj Prabhu's 20+ years of enterprise IT experience at HP and supply chain domains
  • Platform integrates payment trends, clinical trial data, and social media analytics into unified HCP profiles

Watch for

  • No disclosed funding rounds or revenue metrics as of 2026
  • Heavy reliance on pharma sector (90%+ of use cases) creates customer concentration risk
  • Leadership team lacks recent exits or prior life sciences SaaS experience

Key Information

Founded
2010
Headquarters
Pune, India

Frequently Asked Questions

What does Aissel Technologies do?

Aissel Technologies develops AI software for pharmaceutical companies to manage healthcare professional relationships. Their konectar platform analyzes 2M+ HCP profiles using payment records, medical articles, and clinical studies to help pharma teams with KOL identification, engagement tracking, and compliance management. (45 words)

How does konectar help pharmaceutical companies?

Konectar helps pharma teams by analyzing 80M+ HCP payments, 35M+ medical articles, and clinical studies to identify key opinion leaders. The AI platform tracks engagement patterns and ensures compliance, particularly useful for oncology, CNS, and cardiology specialties in mid-to-large pharmaceutical firms. (47 words)

What data sources does Aissel's platform use?

Aissel's konectar platform aggregates data from 80M+ healthcare professional payment records, 35M+ medical journal articles, 479K+ clinical studies, and social media analytics. This creates comprehensive HCP profiles for pharma teams to analyze engagement trends and compliance requirements. (44 words)

Who are Aissel Technologies' main customers?

Aissel primarily serves pharmaceutical medical affairs teams, life sciences commercial units, and clinical trial recruiters. Their platform also supports healthcare compliance officers and medical device manufacturers needing HCP relationship management, with strong adoption in oncology, CNS, and cardiology specialties. (45 words)

How does Aissel compare to Veeva in life sciences SaaS?

Aissel competes with Veeva by focusing specifically on AI-driven HCP relationship management, offering unique datasets like 80M+ payment records. While Veeva has broader CRM capabilities, Aissel specializes in KOL identification and predictive analytics for pharma teams. (46 words)

What are the limitations of Aissel's platform?

Aissel's konectar has heavy pharma sector reliance (90%+ use cases), creating customer concentration risk. The leadership team lacks prior life sciences SaaS exits, and the company hasn't disclosed funding rounds or revenue metrics as of 2026, which may concern some enterprise buyers. (48 words)

Sources

  1. www.aissel.com — konectar product capabilities and dataset scale
  2. www.aissel.com — Leadership team backgrounds
  3. www.aissel.com — Recent pharma CRM positioning
  4. www.aissel.com — KOL software market focus